000 01438 a2200397 4500
005 20250517012658.0
264 0 _c20160204
008 201602s 0 0 eng d
022 _a1440-1843
024 7 _a10.1111/resp.12460
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNakanishi, Yoichi
245 0 0 _aImplementation of modern therapy approaches and research for non-small cell lung cancer in Japan.
_h[electronic resource]
260 _bRespirology (Carlton, Vic.)
_cFeb 2015
300 _a199-208 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAsian People
_xgenetics
650 0 4 _aBiomedical Research
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aErbB Receptors
_xgenetics
650 0 4 _aGenetic Testing
_xeconomics
650 0 4 _aGlucuronosyltransferase
_xgenetics
650 0 4 _aHumans
650 0 4 _aInsurance Coverage
650 0 4 _aInsurance, Health
650 0 4 _aJapan
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNational Health Programs
650 0 4 _aOncogene Proteins, Fusion
_xgenetics
650 0 4 _aPrecision Medicine
773 0 _tRespirology (Carlton, Vic.)
_gvol. 20
_gno. 2
_gp. 199-208
856 4 0 _uhttps://doi.org/10.1111/resp.12460
_zAvailable from publisher's website
999 _c24539825
_d24539825